Aligos Therapeutics Statistics
Total Valuation
ALGS has a market cap or net worth of $28.61 million. The enterprise value is -$19.95 million.
Important Dates
The next estimated earnings date is Tuesday, May 6, 2025, after market close.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ALGS has 6.11 million shares outstanding. The number of shares has increased by 144.38% in one year.
| Current Share Class | 5.31M |
| Shares Outstanding | 6.11M |
| Shares Change (YoY) | +144.38% |
| Shares Change (QoQ) | +0.16% |
| Owned by Insiders (%) | 2.85% |
| Owned by Institutions (%) | 26.66% |
| Float | 4.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.43 |
| Forward PS | 21.04 |
| PB Ratio | -0.99 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.86
| Current Ratio | 2.86 |
| Quick Ratio | 2.62 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -415.84% and return on invested capital (ROIC) is -134.89%.
| Return on Equity (ROE) | -415.84% |
| Return on Assets (ROA) | -50.29% |
| Return on Invested Capital (ROIC) | -134.89% |
| Return on Capital Employed (ROCE) | -184.37% |
| Revenue Per Employee | $56,357 |
| Profits Per Employee | -$1.87M |
| Employee Count | 70 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ALGS has paid $331,000 in taxes.
| Income Tax | 331,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.53% in the last 52 weeks. The beta is 2.72, so ALGS's price volatility has been higher than the market average.
| Beta (5Y) | 2.72 |
| 52-Week Price Change | -77.53% |
| 50-Day Moving Average | 13.06 |
| 200-Day Moving Average | 17.04 |
| Relative Strength Index (RSI) | 27.34 |
| Average Volume (20 Days) | 189,019 |
Short Selling Information
The latest short interest is 823,551, so 13.47% of the outstanding shares have been sold short.
| Short Interest | 823,551 |
| Short Previous Month | 795,342 |
| Short % of Shares Out | 13.47% |
| Short % of Float | 18.83% |
| Short Ratio (days to cover) | 5.47 |
Income Statement
In the last 12 months, ALGS had revenue of $3.95 million and -$131.21 million in losses. Loss per share was -$20.94.
| Revenue | 3.95M |
| Gross Profit | -66.32M |
| Operating Income | -89.15M |
| Pretax Income | -75.52M |
| Net Income | -131.21M |
| EBITDA | -88.13M |
| EBIT | -89.15M |
| Loss Per Share | -$20.94 |
Full Income StatementBalance Sheet
The company has $56.94 million in cash and $8.38 million in debt, giving a net cash position of $48.56 million or $7.94 per share.
| Cash & Cash Equivalents | 56.94M |
| Total Debt | 8.38M |
| Net Cash | 48.56M |
| Net Cash Per Share | $7.94 |
| Equity (Book Value) | -28.97M |
| Book Value Per Share | -7.50 |
| Working Capital | 40.40M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$80.74 million and capital expenditures -$130,000, giving a free cash flow of -$80.87 million.
| Operating Cash Flow | -80.74M |
| Capital Expenditures | -130,000 |
| Free Cash Flow | -80.87M |
| FCF Per Share | -$13.23 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -2,259.92% |
| Pretax Margin | -3,317.62% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ALGS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -144.38% |
| Shareholder Yield | n/a |
| Earnings Yield | -458.54% |
| FCF Yield | -282.62% |
Analyst Forecast
The average price target for ALGS is $70.00, which is 1,392.54% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $70.00 |
| Price Target Difference | 1,392.54% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 131.36% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on August 19, 2024. It was a reverse split with a ratio of 0.04:1.
| Last Split Date | Aug 19, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.04:1 |
Scores
ALGS has an Altman Z-Score of -15.45 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -15.45 |
| Piotroski F-Score | 1 |